Funded startups/PushCART Therapeutics, Inc.

PushCART Therapeutics, Inc.

SEC filing

Biotechnology · Rockville, MD

Form D on EDGAR

Amount raised$500Ksold at filing

Total offering$2M$1.5M still open

Investors in the raise1count reported to the SEC

FiledJul 31, 2026first sale Jul 10, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Sean M. ReinekeDirector

Louis M. WeinerDirector

Albert M. HawkDirector

Stephen D. WolpeExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.